A Trial Assessing the Effect of Nabilone on Pain and Quality of Life in Patients With Fibromyalgia
Completed
Valeant Canada Limited
Phase 2
2006-04-01
The purpose of the study is to determine whether or not the drug Nabilone significantly
reduces pain and improves quality of life in patients with fibromyalgia.
A Trial Assessing the Effect of Nabilone on Pain and Quality of Life in Patients With Fibromyalgia
Completed
Winnipeg Regional Health Authority
Phase 2
2006-04-01
The purpose of the study is to determine whether or not the drug Nabilone significantly
reduces pain and improves quality of life in patients with fibromyalgia.
Nabilone Versus Amitriptyline in Improving Quality of Sleep in Patients With Fibromyalgia
Completed
McGill University Health Center
N/A
2006-04-01
Most chronic pain patients with insomnia are currently not well-managed using existing
medications. If found to safely improve sleep with chronic pain patients, nabilone could be
added to the treatment options available in the management of fibromyalgia and associated
symptoms.
The principle hypothesis of this study is that nabilone at a dose of 0.5-1mg is as
efficacious as amitriptyline at a dose of 10-20mg, in improving sleep quality in patients
with fibromyalgia.
Nabilone Versus Amitriptyline in Improving Quality of Sleep in Patients With Fibromyalgia
Completed
McGill University Health Centre/Research Institute of the McGill University Health Centre
N/A
2006-04-01
Most chronic pain patients with insomnia are currently not well-managed using existing
medications. If found to safely improve sleep with chronic pain patients, nabilone could be
added to the treatment options available in the management of fibromyalgia and associated
symptoms.
The principle hypothesis of this study is that nabilone at a dose of 0.5-1mg is as
efficacious as amitriptyline at a dose of 10-20mg, in improving sleep quality in patients
with fibromyalgia.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.